PMID: 3285121May 1, 1988

Acute graft-versus-host disease: clinical characteristics in the cyclosporine era

Medicine
G B VogelsangG W Santos

Abstract

Graft-versus-host disease (GVHD) remains the major problem in allogeneic bone marrow transplantation. GVHD has limited the use of this technique to HLA-matched donor recipient pairs. Thus, only a quarter of patients who ultimately may have benefited from bone marrow transplantation are currently eligible. Even in matched patient recipient pairs, GVHD accounts for approximately 40% of the deaths following allogeneic bone marrow transplants. One of the major challenges for transplantation is to derive better strategies to prevent and treat GVHD while retaining the allogeneic benefit of graft-versus-leukemia. Current pharmacologic approaches have used cyclosporine, usually in combination with other drugs. More experimental approaches have removed lymphocytes from the marrow grafts. With either approach, maintaining the anti-leukemic benefit of an allogeneic transplant (i.e., immunologic attack of the leukemia resulting in a lower relapse rate), will need to be maintained if that approach will ultimately prove to be useful.

Citations

Nov 1, 1993·Seminars in Surgical Oncology·R H McDowall
Sep 24, 1998·Transplantation Proceedings·H AzizO Imventarza
Jul 1, 1991·Transfusion Medicine Reviews·E M Areman, R A Sacher
May 23, 1998·Journal of Hematotherapy·S J NogaR J Jones
Sep 13, 2000·Clinical Nuclear Medicine·R F NuñezS M Larson
Jun 1, 1994·Journal of Clinical Pathology·A L AppletonA J Malcolm
Jan 1, 1990·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D HeneyI J Lewis
Mar 1, 1989·International Journal of Cell Cloning·G W Santos
Oct 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·J F LacerdaJ M F Lacerda
Jun 11, 2014·Blood·Shernan G HoltanD J Weisdorf
Mar 24, 2010·Pediatric Clinics of North America·Paul A Carpenter, Margaret L Macmillan
Aug 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J P RobertsT Wright
Jan 1, 1997·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·S B WooM M Schubert
Feb 27, 2003·Pediatric Transplantation·Paul A Carpenter, Jean E Sanders
Jan 1, 1990·Postgraduate Medicine·D J Weisdorf
Aug 15, 1993·Hospital Practice·S JagannathG Tricot

Related Concepts

Acute Disease
Cyclosporins
Graft-vs-Host Disease
Lymphoid Cells

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.